ArticleAntimicrobial agents and chemotherapy2013
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Cladosporium halotolerans: Exploring an Unheeded Human Pathogen.Mycopathologia · 2023Pooled it
- From molecular advances to limited clinical impact: The persistent gap in chromoblastomycosis.PLoS neglected tropical diseases · 2026Review
- In Vitro Activities of Five Antifungal Drugs Against Conidia and Sclerotic Cells of Chromoblastomycosis Agent Fonsecaea spp.Microbiology and immunology · 2026Article
- Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies.Current fungal infection reports · 2026Article
- Antifungal Susceptibility of Melanized Fungi Isolated from CARD9 Deficient Patients: Implications for Treatment of Refractory Infections.Mycopathologia · 2025Article
- Genomics and ecology ofIMA fungus · 2025Article
- In vitro Antifungal Susceptibility Profile of ClinicalInfection and drug resistance · 2025Article
- Endogenous fungal endophthalmitis caused by Cladophialophora devriesii: report of a case and literature review.Journal of ophthalmic inflammation and infection · 2024Article
- Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates.IMA fungus · 2024Article
- Article
- Chromoblastomycosis.Clinical microbiology reviews · 2017Review
- In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.Antimicrobial agents and chemotherapy · 2014Article
- In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.Antimicrobial agents and chemotherapy · 2013Article
- Novel treatment using topical malachite green for nasal phaeohyphomycosis caused by a newJFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A global collection of Cladophialophora carrionii strains (n = 81) was tested against nine antifungal drugs. MIC90s of all strains were as follows in increasing order: itraconazole and posaconazole, 0.063 μg/ml; terbinafine, 0.125 μg/ml; isavuconazole and voriconazole, 0.25 μg/ml; caspofungin, 2 μg/ml; micafungin, 4 μg/ml; amphotericin B, 8 μg/ml; and fluconazole, 64 μg/ml.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.